{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T05:17:15Z","timestamp":1732943835131,"version":"3.30.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,29]]},"DOI":"10.7759\/cureus.74728","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T11:29:53Z","timestamp":1732879793000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessment of the Fibrosis Score and the Child-Turcotte-Pugh (CTP) Score in Patients With Chronic Liver Disease in India"],"prefix":"10.7759","author":[{"given":"Madhavi","family":"Sarkari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bechan Kumar","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Overview of cirrhosis","author":"Kamath PS","year":"2015","unstructured":"Kamath PS, Shah VH. Overview of cirrhosis. Sleisenger and Fordtran\u2019s Gastrointestinal and Liver Disease: Pathophysiology\/Diagnosis\/Management, 10th Edition. Elsevier, Philadelphia, PA; 2015. 1254-60.e1."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad AA","year":"2014","unstructured":"Mokdad AA, Lopez AD, Shahraz S, et al.. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014, 12:145. 10.1186\/s12916-014-0145-y","journal-title":"BMC Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07492-2","article-title":"Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease study","volume":"349","author":"Murray CJ","year":"1997","unstructured":"Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease study. Lancet. 1997, 349:1498-504. 10.1016\/S0140-6736(96)07492-2","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure","volume":"142","author":"Garg V","year":"2012","unstructured":"Garg V, Garg H, Khan A, et al.. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology. 2012, 142:505-12.e1. 10.1053\/j.gastro.2011.11.027","journal-title":"Gastroenterology"},{"key":"ref5","article-title":"Approach to the patient with liver disease","author":"Ghany MG","year":"2018","unstructured":"Ghany MG, Hoofnagle JH. Approach to the patient with liver disease. Harrison's Principles of Internal Medicine, Twentieth Edition. Jameson JL, Kasper DK, Longo DL, Fauci AS, Hauser SL, Loscalzo J (ed): McGraw-Hill Education, New York, NY; 2018. 2332-8."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2017.04.005","article-title":"Reversal of liver fibrosis: from fiction to reality","volume":"31","author":"Zoubek ME","year":"2017","unstructured":"Zoubek ME, Trautwein C, Strnad P. Reversal of liver fibrosis: from fiction to reality. Best Pract Res Clin Gastroenterol. 2017, 31:129-41. 10.1016\/j.bpg.2017.04.005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.02.031","article-title":"Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome","volume":"61","author":"Huang Y","year":"2014","unstructured":"Huang Y, de Boer WB, Adams LA, MacQuillan G, Bulsara MK, Jeffrey GP. Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome. J Hepatol. 2014, 61:22-7. 10.1016\/j.jhep.2014.02.031","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01466.x","article-title":"FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy","volume":"102","author":"Shaheen AA","year":"2007","unstructured":"Shaheen AA, Wan AF, Myers RP. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol. 2007, 102:2589-600. 10.1111\/j.1572-0241.2007.01466.x","journal-title":"Am J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010542.pub2","article-title":"Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease","volume":"1","author":"Pavlov CS","year":"2015","unstructured":"Pavlov CS, Casazza G, Nikolova D, Tsochatzis E, Burroughs AK, Ivashkin VT, Gluud C. Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease. Cochrane Database Syst Rev. 2015, 1:CD010542. 10.1002\/14651858.CD010542.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002946","article-title":"AST to platelet ratio index predicts mortality in hospitalized patients with hepatitis B-related decompensated cirrhosis","volume":"95","author":"Mao W","year":"2016","unstructured":"Mao W, Sun Q, Fan J, Lin S, Ye B. AST to platelet ratio index predicts mortality in hospitalized patients with hepatitis B-related decompensated cirrhosis. Medicine (Baltimore). 2016, 95:e2946. 10.1097\/MD.0000000000002946","journal-title":"Medicine (Baltimore)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai CT","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003, 38:518-26. 10.1053\/jhep.2003.50346","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2007.10.011","article-title":"Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B","volume":"40","author":"Shin WG","year":"2008","unstructured":"Shin WG, Park SH, Jang MK, et al.. Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B. Dig Liver Dis. 2008, 40:267-74. 10.1016\/j.dld.2007.10.011","journal-title":"Dig Liver Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21363","article-title":"A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy","volume":"44","author":"Yu ML","year":"2006","unstructured":"Yu ML, Lin SM, Lee CM, et al.. A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy. Hepatology. 2006, 44:1086-97. 10.1002\/hep.21363","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00610.x","article-title":"Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis","volume":"101","author":"Lieber CS","year":"2006","unstructured":"Lieber CS, Weiss DG, Morgan TR, Paronetto F. Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis. Am J Gastroenterol. 2006, 101:1500-8. 10.1111\/j.1572-0241.2006.00610.x","journal-title":"Am J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2006.01287.x","article-title":"Non-invasive models for predicting histology in patients with chronic hepatitis B","volume":"26","author":"Wai CT","year":"2006","unstructured":"Wai CT, Cheng CL, Wee A, et al.. Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int. 2006, 26:666-72. 10.1111\/j.1478-3231.2006.01287.x","journal-title":"Liver Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1177","article-title":"Epidemiology of liver diseases in India","volume":"19","author":"Mondal D","year":"2022","unstructured":"Mondal D, Das K, Chowdhury A. Epidemiology of liver diseases in India. Clin Liver Dis (Hoboken). 2022, 19:114-7. 10.1002\/cld.1177","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling RK","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al.. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006, 43:1317-25. 10.1002\/hep.21178","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah AG","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009, 7:1104-12. 10.1016\/j.cgh.2009.05.033","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-023-07896-3","article-title":"Comparative accuracy of clinical fibrosis markers, Hepascore and Fibroscan\u00ae to detect advanced fibrosis in patients with nonalcoholic fatty liver disease","volume":"68","author":"Bertot LC","year":"2023","unstructured":"Bertot LC, Jeffrey GP, de Boer B, et al.. Comparative accuracy of clinical fibrosis markers, Hepascore and Fibroscan\u00ae to detect advanced fibrosis in patients with nonalcoholic fatty liver disease. Dig Dis Sci. 2023, 68:2757-67. 10.1007\/s10620-023-07896-3","journal-title":"Dig Dis Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo P","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al.. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007, 45:846-54. 10.1002\/hep.21496","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin ZH","year":"2011","unstructured":"Lin ZH, Xin YN, Dong QJ, et al.. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011, 53:726-36. 10.1002\/hep.24105","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.2190","article-title":"Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms","volume":"15","author":"Sebastiani G","year":"2009","unstructured":"Sebastiani G. Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms. World J Gastroenterol. 2009, 15:2190-203. 10.3748\/wjg.15.2190","journal-title":"World J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera L","year":"2008","unstructured":"Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008, 48:835-47. 10.1016\/j.jhep.2008.02.008","journal-title":"J Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong VW","year":"2010","unstructured":"Wong VW, Vergniol J, Wong GL, et al.. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010, 51:454-62. 10.1002\/hep.23312","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-10-103","article-title":"Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis","volume":"10","author":"Friedrich-Rust M","year":"2010","unstructured":"Friedrich-Rust M, Rosenberg W, Parkes J, Herrmann E, Zeuzem S, Sarrazin C. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis. BMC Gastroenterol. 2010, 10:103. 10.1186\/1471-230X-10-103","journal-title":"BMC Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324243","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis","volume":"71","author":"M\u00f3zes FE","year":"2022","unstructured":"M\u00f3zes FE, Lee JA, Selvaraj EA, et al.. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. 2022, 71:1006-19. 10.1136\/gutjnl-2021-324243","journal-title":"Gut"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson S","year":"2010","unstructured":"McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010, 59:1265-9. 10.1136\/gut.2010.216077","journal-title":"Gut"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/314152-assessment-of-the-fibrosis-score-and-the-child-turcotte-pugh-ctp-score-in-patients-with-chronic-liver-disease-in-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T11:29:55Z","timestamp":1732879795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/314152-assessment-of-the-fibrosis-score-and-the-child-turcotte-pugh-ctp-score-in-patients-with-chronic-liver-disease-in-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.74728","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,29]]}}}